161 related articles for article (PubMed ID: 23560736)
1. Characterization of MYC-induced tumorigenesis by in situ lipid profiling.
Perry RH; Bellovin DI; Shroff EH; Ismail AI; Zabuawala T; Felsher DW; Zare RN
Anal Chem; 2013 May; 85(9):4259-62. PubMed ID: 23560736
[TBL] [Abstract][Full Text] [Related]
2. Regulation of glycosylphosphatidylinositol-anchored proteins and GPI-phospholipase D in a c-Myc transgenic mouse model of hepatocellular carcinoma and human HCC.
Ritorto MS; Rhode H; Vogel A; Borlak J
Biol Chem; 2016 Nov; 397(11):1147-1162. PubMed ID: 27232633
[TBL] [Abstract][Full Text] [Related]
3. Generation of combined hepatocellular-cholangiocarcinoma through transdifferentiation and dedifferentiation in p53-knockout mice.
Liu Y; Xin B; Yamamoto M; Goto M; Ooshio T; Kamikokura Y; Tanaka H; Meng L; Okada Y; Mizukami Y; Nishikawa Y
Cancer Sci; 2021 Aug; 112(8):3111-3124. PubMed ID: 34051011
[TBL] [Abstract][Full Text] [Related]
4. Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.
Zimonjic DB; Ullmannova-Benson V; Factor VM; Thorgeirsson SS; Popescu NC
Cancer Genet Cytogenet; 2009 May; 191(1):17-26. PubMed ID: 19389504
[TBL] [Abstract][Full Text] [Related]
5. c-Myc-driven Hepatocarcinogenesis.
Moon H; Park H; Ro SW
Anticancer Res; 2021 Oct; 41(10):4937-4946. PubMed ID: 34593441
[TBL] [Abstract][Full Text] [Related]
6. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
7. Myelocytomatosis-Protein Arginine N-Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma.
Luo Y; Gao Y; Liu W; Yang Y; Jiang J; Wang Y; Tang W; Yang S; Sun L; Cai J; Guo X; Takahashi S; Krausz KW; Qu A; Chen L; Xie C; Gonzalez FJ
Hepatology; 2021 Oct; 74(4):1932-1951. PubMed ID: 33896016
[TBL] [Abstract][Full Text] [Related]
8. The MYC Oncogene Cooperates with Sterol-Regulated Element-Binding Protein to Regulate Lipogenesis Essential for Neoplastic Growth.
Gouw AM; Margulis K; Liu NS; Raman SJ; Mancuso A; Toal GG; Tong L; Mosley A; Hsieh AL; Sullivan DK; Stine ZE; Altman BJ; Schulze A; Dang CV; Zare RN; Felsher DW
Cell Metab; 2019 Sep; 30(3):556-572.e5. PubMed ID: 31447321
[TBL] [Abstract][Full Text] [Related]
9. Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
Xin B; Yamamoto M; Fujii K; Ooshio T; Chen X; Okada Y; Watanabe K; Miyokawa N; Furukawa H; Nishikawa Y
Oncogene; 2017 Sep; 36(36):5087-5097. PubMed ID: 28481866
[TBL] [Abstract][Full Text] [Related]
10. A transgenic zebrafish liver tumor model with inducible Myc expression reveals conserved Myc signatures with mammalian liver tumors.
Li Z; Zheng W; Wang Z; Zeng Z; Zhan H; Li C; Zhou L; Yan C; Spitsbergen JM; Gong Z
Dis Model Mech; 2013 Mar; 6(2):414-23. PubMed ID: 23038063
[TBL] [Abstract][Full Text] [Related]
11. MYC and MET cooperatively drive hepatocellular carcinoma with distinct molecular traits and vulnerabilities.
Sequera C; Grattarola M; Holczbauer A; Dono R; Pizzimenti S; Barrera G; Wangensteen KJ; Maina F
Cell Death Dis; 2022 Nov; 13(11):994. PubMed ID: 36433941
[TBL] [Abstract][Full Text] [Related]
12. Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
Coulouarn C; Gomez-Quiroz LE; Lee JS; Kaposi-Novak P; Conner EA; Goldina TA; Onishchenko GE; Factor VM; Thorgeirsson SS
Hepatology; 2006 Oct; 44(4):1003-11. PubMed ID: 17006931
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
Zhang JF
Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
[TBL] [Abstract][Full Text] [Related]
14. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
15. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes.
Li Z; Zheng W; Li H; Li C; Gong Z
PLoS One; 2015; 10(7):e0132319. PubMed ID: 26147004
[TBL] [Abstract][Full Text] [Related]
17. ELP3 stabilizes c-Myc to promote tumorigenesis.
Zhao W; Ouyang C; Huang C; Zhang J; Xiao Q; Zhang F; Wang H; Lin F; Wang J; Wang Z; Jiang B; Li Q
J Mol Cell Biol; 2024 Apr; 15(9):. PubMed ID: 37771073
[TBL] [Abstract][Full Text] [Related]
18. Alteration of the lipid profile in lymphomas induced by MYC overexpression.
Eberlin LS; Gabay M; Fan AC; Gouw AM; Tibshirani RJ; Felsher DW; Zare RN
Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10450-5. PubMed ID: 24994904
[TBL] [Abstract][Full Text] [Related]
19. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
20. CSIG promotes hepatocellular carcinoma proliferation by activating c-MYC expression.
Cheng Q; Yuan F; Lu F; Zhang B; Chen T; Chen X; Cheng Y; Li N; Ma L; Tong T
Oncotarget; 2015 Mar; 6(7):4733-44. PubMed ID: 25749381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
